Bergan Kdv Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Bergan Kdv Wealth Management, LLC

$999 Million
Q2 2023

A detailed history of Bergan Kdv Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 5,837 shares of VRTX stock, worth $2.39 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,837

Previous 6,421 9.1%

Holding current value

$2.39 Million

Previous $2.02 Million 1.53%

% of portfolio

0.21%

Previous 0.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$314.42 - $351.91 $183,621 - $205,515	-584 Reduced 9.1%	5,837 $2.05 Million
Q1 2023 Apr 27, 2023	BUY	$283.23 - $323.1 $8,780 - $10,016	31 Added 0.49%	6,421 $2.02 Million
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $17,145 - $19,288	60 Added 0.95%	6,390 $1.85 Million
Q3 2022 Oct 24, 2022	SELL	$273.83 - $305.53 $65,993 - $73,632	-241 Reduced 3.67%	6,330 $1.83 Million
Q2 2022 Jul 13, 2022	BUY	$234.96 - $292.55 $53,805 - $66,993	229 Added 3.61%	6,571 $1.85 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $166,729 - $196,510	753 Added 13.47%	6,342 $1.66 Million
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $14,514 - $18,322	-82 Reduced 1.45%	5,589 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $460,186 - $514,985	2,537 Added 80.95%	5,671 $1.03 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $9,749 - $11,497	52 Added 1.69%	3,134 $632,000
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $17,182 - $20,028	83 Added 2.77%	3,082 $662,000
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $611,300 - $815,293	2,953 Added 6419.57%	2,999 $709,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $5,186 - $6,803	23 Added 100.0%	46 $13,000
Q1 2020 Apr 24, 2020	BUY	$199.77 - $247.81 $1,797 - $2,230	9 Added 64.29%	23 $5,000
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $2,333 - $3,134	14 New	14 $3,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.

Account

Bergan Kdv Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History